Literature DB >> 16391993

Resolution of tachycardia-induced cardiomyopathy following ablation of verapamil-sensitive idiopathic left ventricular tachycardia.

A Arya1, M Haghjoo2, P Davari3, M A Sadr-Ameli2.   

Abstract

Few reports have described tachycardia-induced cardiomyopathy secondary to ventricular tachycardia. We present a 12-year-old boy with dilated cardiomyopathy and incessant verapamil-sensitive idiopathic left ventricular tachycardia. Twelve-lead electrocardiogram showed right bundle branch block QRS morphology with superior axis during tachycardia. Electrophysiology study confirmed the diagnosis, and radiofrequency ablation was done and successfully terminated and prevented induction of ventricular tachycardia. During the follow-up period of 18 months, the patient remained free of symptoms and arrhythmia. Three months after ablation, left ventricular ejection fraction improved and cardiac silhouette became normal on chest x-ray.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16391993     DOI: 10.1007/s00246-005-1091-4

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  17 in total

1.  Radiofrequency catheter ablation of idiopathic ventricular tachycardias in children.

Authors:  J L Smeets; L M Rodriguez; C Timmermans; H J Wellens
Journal:  Pacing Clin Electrophysiol       Date:  1997-08       Impact factor: 1.976

2.  Reversal of tachycardia induced cardiomyopathy following ablation of repetitive monomorphic right ventricular outflow tract tachycardia.

Authors:  W Grimm; V Menz; J Hoffmann; B Maisch
Journal:  Pacing Clin Electrophysiol       Date:  2001-02       Impact factor: 1.976

Review 3.  Tachycardia-induced cardiomyopathy: a review of literature.

Authors:  Atul Khasnis; Krit Jongnarangsin; George Abela; Srikar Veerareddy; Vivek Reddy; Ranjan Thakur
Journal:  Pacing Clin Electrophysiol       Date:  2005-07       Impact factor: 1.976

Review 4.  Tachycardiomyopathy: mechanisms and clinical implications.

Authors:  G Fenelon; W Wijns; E Andries; P Brugada
Journal:  Pacing Clin Electrophysiol       Date:  1996-01       Impact factor: 1.976

5.  Tachycardia-induced cardiomyopathy secondary to right ventricular outflow tract ventricular tachycardia: improvement of left ventricular systolic function after radiofrequency catheter ablation of the arrhythmia.

Authors:  J Vijgen; P Hill; L A Biblo; M D Carlson
Journal:  J Cardiovasc Electrophysiol       Date:  1997-04

6.  Idiopathic sustained left ventricular tachycardia in pediatric patients.

Authors:  K Yasui; T Shibata; U Yokoyama; T Nishizawa; K Takigiku; T Sakon; H Kobayashi; M Iwamoto; I Niimura
Journal:  Pediatr Int       Date:  2001-02       Impact factor: 1.524

7.  Congestive heart failure following chronic tachycardia.

Authors:  H N Coleman; R R Taylor; P E Pool; G H Whipple; J W Covell; J Ross; E Braunwald
Journal:  Am Heart J       Date:  1971-06       Impact factor: 4.749

8.  [Reversibility of cardiomyopathy after therapy of incessant left ventricular tachycardia with radiofrequency ablation in a newborn infant].

Authors: 
Journal:  An Esp Pediatr       Date:  2000-08

9.  Comparison of presystolic purkinje and late diastolic potentials for selection of ablation site in idiopathic verapamil sensitive left ventricular tachycardia.

Authors:  Arash Arya; Majid Haghjoo; Zahra Emkanjoo; Amir Farjam Fazelifar; Mohammad Reza Dehghani; Alireza Heydari; Mohammad Ali Sadr-Ameli
Journal:  J Interv Card Electrophysiol       Date:  2004-10       Impact factor: 1.900

10.  Radiofrequency catheter ablation of idiopathic left ventricular tachycardia in a child.

Authors:  Meng-Hsun Lin; Wen-Chin Ko; Nan-Koong Wang; Ching-Tsuen Shen
Journal:  Acta Paediatr Taiwan       Date:  2004 Jan-Feb
View more
  1 in total

1.  Incessant fascicular VT presenting as cardiogenic shock with multi-organ dysfunction syndrome.

Authors:  Ankur C Thummar; Ganesh Patil; Ashar Khan; Yash Y Lokhandwala; Ajay U Mahajan; Pratap J Nathani
Journal:  J Cardiol Cases       Date:  2016-02-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.